Himma Investments
Loading account and display preferences…
Loading application
Himma Investments
Home
Portfolio
News
Earnings
Macro
Special Situations
Themes
Log in
Sign up
Home
Portfolio
News
Earnings
Macro
Special Situations
Themes
Loading market prices…
New York
FILTERS · MARKET-WIDE · ALL SCORES
Sign in
to filter the news.
SYMBOL
Apply
COVERAGE
Market-wide
Portfolio + Watchlist
Portfolio
MIN SCORE
All
≥5
≥7
≥9
CATEGORIES
Guidance
0
Analyst
0
Regulatory
0
M&A
0
Macro
0
Capital
0
Other
0
Filings · routine
0
Insider
0
Himma Investments
Home
Portfolio
News
Earnings
Macro
Special Situations
Themes
Log in
Sign up
Home
Portfolio
News
Earnings
Macro
Special Situations
Themes
SPY 767.50
+1.7%
DIA 533.43
+3.2%
QQQ 689.29
+0.6%
GLD 372.80
+3.8%
BTC 80,668.00
+5.5%
USO 145.00
−8.3%
New York
NEWS
Checks for new events every 30s
WEDNESDAY, NOV 4
08:00
RYTM
Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome
8
TUESDAY, NOV 3
08:10
RYTM
Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update
8
MONDAY, NOV 2
21:59
RYTM
Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement
9
TUESDAY, OCT 13
19:30
RYTM
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
7
The wire runs all day · you're seeing 4 of 4 available events
Continue with Google
One click · free · no card
